Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
B 128.38 -0.57% -0.73
SRPT closed down 0.57 percent on Thursday, March 23, 2023, on 66 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 50 DMA Bearish -0.57%
Calm After Storm Range Contraction -0.57%
Narrow Range Bar Range Contraction -0.57%
Multiple of Ten Bearish Other -0.57%
Wide Bands Range Expansion -0.57%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 10 hours ago
Down 1% about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Fell Below Previous Day's Low about 13 hours ago
50 DMA Resistance about 14 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sarepta Therapeutics, Inc. Description

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Infectious Diseases Clinical Development Rare Diseases Clinical Research Influenza Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Therapeutic Gene Modulation Antisense RNA Sarepta Therapeutics

Is SRPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 159.835
52 Week Low 61.28
Average Volume 1,432,101
200-Day Moving Average 110.92
50-Day Moving Average 130.13
20-Day Moving Average 140.00
10-Day Moving Average 136.95
Average True Range 7.42
RSI 44.13
ADX 22.84
+DI 27.05
-DI 33.56
Chandelier Exit (Long, 3 ATRs) 137.57
Chandelier Exit (Short, 3 ATRs) 139.38
Upper Bollinger Bands 165.08
Lower Bollinger Band 114.93
Percent B (%b) 0.27
BandWidth 35.82
MACD Line 0.38
MACD Signal Line 3.17
MACD Histogram -2.7974
Fundamentals Value
Market Cap 10.13 Billion
Num Shares 78.9 Million
EPS -8.14
Price-to-Earnings (P/E) Ratio -15.78
Price-to-Sales 23.81
Price-to-Book 13.56
PEG Ratio 159.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 136.56
Resistance 3 (R3) 136.56 133.84 135.19
Resistance 2 (R2) 133.84 131.76 133.84 134.74
Resistance 1 (R1) 131.11 130.47 129.75 131.11 134.28
Pivot Point 128.39 128.39 127.71 128.39 128.39
Support 1 (S1) 125.66 126.31 124.30 125.66 122.48
Support 2 (S2) 122.94 125.02 122.94 122.02
Support 3 (S3) 120.21 122.94 121.57
Support 4 (S4) 120.21